Literature DB >> 15117122

The epidemiology of hepatitis a virus infection in children, in Edirne, Turkey.

Mehmet Sarper Erdoğan1, Metin Otkun, Muserref Tatman-Otkun, Filiz Akata, Mevlut Türe.   

Abstract

Turkey is a middle endemic area with respect to Hepatitis A virus (HAV) infection. However, the frequency of this infection varies due to socio-economic differences in various regions. The aim of this study was to detect the most likely age of exposure to HAV and factors affecting infection rates among children living in Edirne. A sample of 645 children between the ages of 0-19 living in Edirne were tested for total anti-HAV levels using ELISA method. A questionnaire on socio-economic status (SES), possible risk factors, and place of residence was completed for each child. Anti-HAV seropositivity was found to be 4.4, 25, 37.3 and 43.2%, in 2-5, 6-10, 11-14 and 15-19 age groups, respectively. Seropositivity was found to be increasing with age (p < 0.05). According to logistic regression analysis results; mother's education, SES of family, history of hepatitis in primary family members and the number of brothers or sisters were determined as factors increasing the seropositivity of HAV. Furthermore, HAV infection risk was found to be a decreasing function of income that is higher the income less likely the infection. These results showed that HAV infection rate in Edirne is in middle endemicity and the most likely way of exposure is transmission from family members. Although it requires further cost-effectiveness studies, our results indicate that applying the HAV vaccination in early childhood would be beneficial to decrease the prevalence of the infection and prevent HAV epidemics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117122     DOI: 10.1023/b:ejep.0000020344.55498.1d

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

1.  Prevalence of hepatitis A, B and C in Turkey.

Authors:  L Doganci; T Haznedaroglu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

2.  Assessing hepatitis A virus epidemic stochastic process in eight cities in China in 1990.

Authors:  J Geng; D Xu; J Gong; W Li
Journal:  Int J Epidemiol       Date:  1998-04       Impact factor: 7.196

3.  The seroprevalence of anti-HAV among 0-16-year-olds referred to pediatric outpatients clinics of a hospital.

Authors:  B Ersoy; A Aydoğan; A Dinçoğuz; M Sinan Meral; T Turul
Journal:  J Trop Pediatr       Date:  1998-02       Impact factor: 1.165

4.  Hepatitis A shifting epidemiology in Latin America.

Authors:  J Tanaka
Journal:  Vaccine       Date:  2000-02-18       Impact factor: 3.641

5.  Hepatitis A shifting epidemiology in Poland and Eastern Europe.

Authors:  J Cianciara
Journal:  Vaccine       Date:  2000-02-18       Impact factor: 3.641

6.  Hepatitis A shifting epidemiology in the Middle East and Africa.

Authors:  H Tufenkeji
Journal:  Vaccine       Date:  2000-02-18       Impact factor: 3.641

7.  Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1999-10-01

8.  Prevalence of antibody to hepatitis A virus among children in Trabzon, Turkey.

Authors:  A Baki; M Aynaci; I Köksal
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

9.  [Outbreaks of hepatitis A in the City of Havana in the year 1991].

Authors:  A Balmaseda Hechavarría; P Más Lago; M A Ribas; L Rodríguez Lay; G Delgado
Journal:  Rev Cubana Med Trop       Date:  1994

10.  The epidemiology of hepatitis B virus among family members in the Middle East.

Authors:  A U Toukan; Z K Sharaiha; O A Abu-el-Rub; M K Hmoud; S S Dahbour; H Abu-Hassan; S M Yacoub; S C Hadler; H S Margolis; P J Coleman
Journal:  Am J Epidemiol       Date:  1990-08       Impact factor: 4.897

View more
  5 in total

1.  Relationship between antioxidant capacity and oxidative stress in children with acute hepatitis A.

Authors:  Mustafa Cemek; Semiha Dede; Fahri Bayiroglu; Huseyin Caksen; Fatma Cemek; Nihat Mert
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

2.  Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey.

Authors:  Ahmet Soysal; Ibrahim Gokçe; Tamer Pehlivan; Mustafa Bakir
Journal:  Eur J Pediatr       Date:  2007-02-22       Impact factor: 3.183

3.  Shifting epidemiology of hepatitis a infection and vaccination status of children aged 6 months-12 years: time for mass vaccination.

Authors:  Burcin Nalbantoglu; Metin M Donma; Burcu Ozdilek; Erkut Karasu; Aysin Nalbantoglu
Journal:  Iran J Pediatr       Date:  2013-06       Impact factor: 0.364

4.  Comparison of the Prevalence and Risk Factors of Hepatitis A in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The CASPIAN-III Study.

Authors:  Nasser Mostafavi; Roya Kelishadi; Elham Kazemi; Behrooz Ataei; Majid Yaran; Mohammad Esmaeil Motlagh; Mostafa Qorbani; Ramin Heshmat; Mohamad Hasan Tajadini; Shervin Ghaffari Hoseini
Journal:  Hepat Mon       Date:  2016-08-17       Impact factor: 0.660

5.  Seropositivity of Hepatitis A in Children Aged 7-14 Years in Diyarbakir Province Center.

Authors:  Ayfer Gözü Pirinççioğlu; Salih Adıgüzel; Tuncer Özekinci
Journal:  Med Sci Monit       Date:  2018-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.